UgenTec raises 1.4M in seed funding

Wouter Uten | Funding | 10/04/2015

We are proud to announce that we have received more than €1M in venture capital funding from a group of Belgian investors and an additional €250 000 in research funds from the IWT, a government agency for Innovation by Science and Technology.

The investors include former MedHold CEO Annie Vereecken, Cartagenia CEO Herman Verrelst and a KULeuven investment group led by professor Bart De Moor.

LRM, a Belgian investment company, will also support UgenTec with a loan of €100,000.

Read the official press release.

Read the article in Genomeweb.

UgenTec, an innovative software provider for molecular diagnostics, today announced it won a $550,000 (€490,000) grant from the Flemish government (VL...
We're excited to announce our series A funding round. Existing and new investors subscribed to the round for a total worth of $9,3 million (€7,5 milli...
BRUSSELS, BELGIUM and HASSELT, BELGIUM—. UgenTec, the Belgian PCR automation software company is approved for the SME Instrument Phase 1 by the Europe...
UgenTec, the Belgian company that is developing independent PCR analysis software based on artificial intelligence and machine learning, closed a €2.1...